Bayer Starts Key Trials for Thrombosis Drug in Pipeline Revival – Bloomberg.com

Bayer AG launched pivotal late-stage studies of a new thrombosis prevention drug as the German pharma company seeks to refresh a portfolio …
Read Complete New : Bayer Starts Key Trials for Thrombosis Drug in Pipeline Revival – Bloomberg.com